- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Order entry system attacks wasteful imaging referrals
Order entry system attacks wasteful imaging referrals
Two years of experience with Massachusetts General Hospital’s radiology order entry system indicate the decision-support features embedded in the software cut down on inappropriate image utilization. They also help referring doctors learn the most appropriate imaging application for specific symptomatic indications.
MGH fellow Pragya Dang conducted an evaluation of the system from the fourth quarter of 2004 to the fourth quarter of 2006. Dang found low-utility CT exams decreased from 11% of the total volume before implementation to 4% by the end of the study period. High-utility CT exams rose significantly in the same period, from 86% before implementation to 93% after referrers learned to use the system.
The same trend was seen for MR utilization. Clinical indications with the highest prevalence of inappropriate study order patterns included dementia, syncope, chronic headache, and back pain. Dang reported the results at the 2007 RSNA meeting.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
